Erythrodermic atopic dermatitis resistant to dupilumab and baricitinib successfully treated with upadacitinib

J Eur Acad Dermatol Venereol. 2023 Apr;37(4):e493-e495. doi: 10.1111/jdv.18714. Epub 2022 Nov 5.

Authors

Clara Valente¹, Bruno Duarte¹

Affiliation

¹ Dermatology and Venereology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.

PMID: 36306182
DOI: 10.1111/jdv.18714

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Dermatitis, Atopic* / drug therapy
Humans
Severity of Illness Index
Treatment Outcome

Substances

dupilumab
baricitinib
upadacitinib
Antibodies, Monoclonal, Humanized